South Africa
Africa Faces 40% Health Funding Cliff; Leaders Seek New Investment Models
Africa

Africa Faces 40% Health Funding Cliff; Leaders Seek New Investment Models

Continent confronts 40% aid decline; pivots toward domestic financing and regional self-reliance.

A projected 40% drop in health aid by 2025, compared to 2023 levels, set the financial stakes for the Africa Health Sovereignty Summit before a single session convened. Ghana hosted the three-day gathering from 4 to 6 August 2025 in Accra, drawing African Heads of State, Ministers of Health and Finance, private sector actors, and global health leaders to confront a structural crisis in how the continent funds its health systems.

The core problem is decades in the making. Africa’s health economics have long rested on external aid for system operations, medicine procurement, and outbreak response. That model is now under acute pressure. Global health funding is contracting sharply at precisely the moment the continent’s health needs are expanding, and the summit’s organizers framed the response in blunt terms: Africa must shift toward domestic resource mobilization, local manufacturing capacity, and regional financial cooperation.

WHO Director-General Dr Tedros Adhanom Ghebreyesus delivered the sharpest diagnosis of the financing gap. “This is not a gradual shift; it is a cliff edge,” he told delegates. “Africa must invest in its own systems. The future of global health security depends on the strength of national systems.” Dr Tedros traveled to Accra alongside WHO Regional Director for Africa Dr Mohammed Yakubu Janabi, whose presence anchored the organization’s institutional commitment to Universal Health Coverage and expanded local access to medical technologies.

Ghana’s President John Dramani Mahama reframed the entire investment case. Health spending, he argued in his keynote, is not a cost burden but an economic asset. “We must reject the outdated notion that health drains our economies. Health is the engine of our productivity and the bedrock of inclusive growth.” Dr Tedros met separately with President Mahama to discuss Ghana’s health priorities and partnership frameworks, and also visited the WHO Ghana Country Office to engage staff directly.

Meanwhile, Dr Janabi ran a parallel track of high-level engagements across his three-day visit. He met with Ghana’s Minister of Health, Hon. Kwabena Mintah Akandoh, to align on national health priorities and strengthen WHO’s operational support. He also convened Heads of UN Agencies in Ghana to push for coordinated action aimed at accelerating health-related Sustainable Development Goals.

One commitment moved from pledge to delivery on the ground. Dr Janabi handed over Mpox response supplies valued at USD 36,700 to Ghana’s health authorities, a package that included personal protective equipment and GeneXpert cartridges. The handover operationalized WHO’s stated commitment to rapid response capacity in the face of emerging health threats, a small but concrete signal of the kind of in-country investment the summit was designed to catalyze.

Dr Janabi also participated in major media interviews with JoyNews and BBC, articulating WHO Africa’s strategic direction. He emphasized regional health leadership, greater country ownership of health agendas, and a deliberate shift away from aid dependency. Local solutions, innovation, and strengthened partnerships were the mechanisms he outlined for transforming health outcomes across the continent.

At a townhall with WHO Ghana Country Office staff, Dr Janabi discussed operational priorities with field teams and created space for staff to exchange ideas on enhancing country-level impact.

The summit’s closing panel distilled the financing philosophy that had animated the entire gathering. “True health sovereignty starts with shared responsibility,” Dr Janabi said. “Development partners must walk alongside African countries, not ahead of them. Mutual accountability and country leadership are key to lasting change.” The framing repositions development partners from architects of health systems to collaborators within them, a distinction with real implications for how capital flows and who controls procurement, manufacturing, and institutional design.

The summit’s output extended beyond declarations. It crystallized a strategic reorientation toward domestic financing and regional self-reliance. WHO committed to translating summit ambitions into concrete operational support, working with Member States to build the manufacturing and institutional capacity required for health systems no longer dependent on volatile external funding. Full documentation of WHO’s engagement is available at https://www.afro.who.int/countries/ghana/photo-story/africa-charts-new-path-health-sovereignty-who-leadership-joins-ghana.

The open question now is whether the domestic revenue mobilization the summit called for can be structured and scaled fast enough to absorb the funding cliff before it arrives.

Q&A

What is the projected scale of the health funding decline Africa faces by 2025?

A 40% drop in health aid by 2025 compared to 2023 levels.

What financing model shift did the Africa Health Sovereignty Summit call for?

Transition from external aid dependency toward domestic resource mobilization, local manufacturing capacity, and regional financial cooperation.

What was the value and composition of WHO's Mpox response supply handover to Ghana?

USD 36,700 in supplies including personal protective equipment and GeneXpert cartridges, delivered by WHO Regional Director Dr Janabi to Ghana's health authorities.

How did Ghana's President reframe the economic case for health spending?

As an economic asset and engine of productivity and inclusive growth, rejecting the notion that health spending drains economies.